Black Diamond Therapeutics, Inc. (BDTX)

1.895 +0.04 (+2.43%) USD  |  NASDAQ  |  Jun 09, 16:00
1.895 0.00 (0.00%) After-Hours: 20:00
More

Black Diamond Therapeutics SG&A Expense (Quarterly) : 4.256M for March 31, 2026

SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for BDTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
Editas Medicine, Inc. 10.23M
Johnson & Johnson 6.034B
Agenus, Inc. 6.86M
Amgen, Inc. 1.602B
BioCryst Pharmaceuticals, Inc. 94.55M